Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Brain Neoplasm|Second Neoplasm
Interventions: DRUG: temozolomide
Sponsor: Merck Sharp & Dohme LLC